Moll Wendén advised AegirBio AB on the deal.AegirBio AB is implementing a preferential rights issue of units to existing shareholders. If the rights issue is fully…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
